PA
ALXN

Profund Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-57,295
Closed -$10.5M 1473
2021
Q2
$10.5M Sell
57,295
-1,327
-2% -$244K 0.35% 47
2021
Q1
$8.96M Sell
58,622
-1,278
-2% -$195K 0.34% 49
2020
Q4
$9.36M Buy
59,900
+4,503
+8% +$704K 0.41% 39
2020
Q3
$6.34M Sell
55,397
-7,815
-12% -$894K 0.33% 52
2020
Q2
$7.1M Buy
63,212
+7,729
+14% +$868K 0.39% 38
2020
Q1
$4.98M Sell
55,483
-18,540
-25% -$1.66M 0.37% 45
2019
Q4
$8.01M Buy
74,023
+6,624
+10% +$716K 0.35% 48
2019
Q3
$6.6M Sell
67,399
-3,795
-5% -$372K 0.33% 46
2019
Q2
$9.33M Sell
71,194
-5,476
-7% -$717K 0.44% 35
2019
Q1
$10.4M Buy
76,670
+1,355
+2% +$183K 0.5% 30
2018
Q4
$7.33M Sell
75,315
-18,003
-19% -$1.75M 0.45% 36
2018
Q3
$13M Buy
93,318
+8,387
+10% +$1.17M 0.49% 30
2018
Q2
$10.5M Sell
84,931
-4,240
-5% -$526K 0.42% 35
2018
Q1
$9.94M Sell
89,171
-7,626
-8% -$850K 0.4% 39
2017
Q4
$11.6M Sell
96,797
-10,447
-10% -$1.25M 0.45% 36
2017
Q3
$15M Buy
107,244
+6,706
+7% +$941K 0.63% 22
2017
Q2
$12.2M Sell
100,538
-5,706
-5% -$694K 0.55% 26
2017
Q1
$12.9M Sell
106,244
-6,904
-6% -$837K 0.58% 25
2016
Q4
$13.8M Sell
113,148
-15,851
-12% -$1.94M 0.64% 24
2016
Q3
$15.8M Sell
128,999
-5,067
-4% -$621K 0.75% 17
2016
Q2
$15.7M Sell
134,066
-7,447
-5% -$870K 0.76% 18
2016
Q1
$19.7M Sell
141,513
-32,550
-19% -$4.53M 1.02% 13
2015
Q4
$33.2M Buy
174,063
+93
+0.1% +$17.7K 1.58% 10
2015
Q3
$27.2M Sell
173,970
-7,217
-4% -$1.13M 1.55% 9
2015
Q2
$32.8M Buy
181,187
+14,657
+9% +$2.65M 1.36% 9
2015
Q1
$28.9M Buy
166,530
+11,436
+7% +$1.98M 1.12% 11
2014
Q4
$28.7M Buy
155,094
+15,662
+11% +$2.9M 1.17% 11
2014
Q3
$23.1M Buy
139,432
+9,630
+7% +$1.6M 1.08% 12
2014
Q2
$20.3M Sell
129,802
-32,278
-20% -$5.04M 0.89% 12
2014
Q1
$24.7M Buy
162,080
+29,066
+22% +$4.42M 1.12% 11
2013
Q4
$17.7M Buy
133,014
+26,431
+25% +$3.52M 0.79% 12
2013
Q3
$12.4M Buy
106,583
+5,339
+5% +$620K 0.66% 15
2013
Q2
$9.34M Buy
+101,244
New +$9.34M 0.66% 18